Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes
NIDDK plans to fund research on how digital health technologies—like apps, devices, and telemedicine—can improve the management of type 2 diabetes.
Funder: National Institutes of Health (NIH)
Due Dates: November 7, 2025 | October 6, 2026
Funding Amounts: Application budgets are not limited; maximum project period is 5 years; estimated program funding: $1.5M in FY2026, $3.0M/year in FY2027–2030, $1.5M in FY2031; 3 awards expected.
Summary: Supports clinical trials evaluating the efficacy of digital health technology approaches for the remote management of type 2 diabetes.
Key Information: Only clinical trial applications are accepted; foreign organizations are not eligible.
Description
This funding opportunity seeks to advance research on the efficacy and clinical effectiveness of multimodality digital health technology (DHT) approaches for the remote management of type 2 diabetes (T2D). With the rising prevalence of T2D and increasing strain on healthcare systems, digital health interventions—including continuous glucose monitoring, telemedicine, wearable devices, mHealth apps, and digital peer support—offer promising avenues for improving patient engagement, glycemic control, and overall diabetes outcomes. The program emphasizes rigorously designed clinical trials that can lay the groundwork for future large-scale effectiveness studies.
